PATENT CLAIM ANALYSIS

Application Number: 15897025
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "186100"]

Abstract:
The invention compositions comprising a continuous hydrophobic phase and liposomes as a vehicle for delivery of an antigen capable of inducing a cytotoxic T lymphocyte (CTL) response and methods for their use in the treatment of cancer.

Claim (Index 55):
The method of  claim 47 , further comprising encapsulating an adjuvant in said liposomes or combining an adjuvant with said carrier.

Metadata:
- Claim Count in Document: 92.0
- Percentile: 88.0
- Lexical Diversity: 1.17647
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14674063', '14736897', '12846092', '12043656', '10524936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6703913241014082
- 35 USC 102 Novelty (BERT): 0.5953502736448877
- Combined Prediction Score: 0.6628872190557562
- Mean Citation Score: 353.402728
- Max Citation Score: 611.6932400000002
- Similarity Product: 388.6845762868549

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test